Revenue reached $67.2 billion, beating analyst estimates by 7.3% (non-GAAP) and growing 11% year over year. Adjusted earnings per share (EPS) rose to $7.20, surpassing expectations and EPS increased 7 ...

A s a college student, I studied pre-med, but I wasn’t sure what kind of "med" was right for me. That changed when a local pharmacist spoke to my Ohio Northern University class, sharing stories of the ...

DOJ probes, vertical integration risks, shaky earnings quality, and fading investor trust despite strong headline profits ...

UNH's oversold status has been overly done, as the market digests the market-wide headwinds arising from regulatory changes ...

DOJ probes, vertical integration risks, shaky earnings quality, and fading investor trust despite strong headline profits ...

Cigna reported impressive financial results for Q2 2025, with total revenue reaching $67.2 billion and adjusted earnings per share (EPS) of $7.20. The company reaffirmed its full-year 2025 outlook, ...